Post-earnings recap
Reported
Thu, Apr 28, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a slight miss on EPS, which contributed to a 0.91% decline in stock price. The company did not provide revenue figures or guidance, leaving investors with uncertainty. Management's cautious tone suggests they are aware of market challenges but remain focused on long-term growth strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.34 | N/A | -4.49% |
Management expressed a cautious optimism about future growth despite current challenges. They emphasized their commitment to long-term strategies.
We remain focused on our long-term growth strategy.
Market conditions continue to present challenges.